Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Zai Lab ADR | ZLAB | Apr 29, 2024 | 16.12 | +1.32 |
Zalatoris II Acquisition | ZLS | Apr 29, 2024 | 10.88 | 0.00 |
Zapata Computing | ZPTA | Apr 29, 2024 | 1.50 | 0.00 |
Zapp Electric Vehicles Group | ZAPP | Apr 29, 2024 | 2.77 | -3.15 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Apr 29, 2024 | 43.60 | +0.53 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Apr 29, 2024 | 58.46 | +0.45 |
Zebra Technologies A | ZBRA | Apr 29, 2024 | 300.01 | +0.94 |
Zedge B | ZDGE | Apr 29, 2024 | 2.53 | +5.86 |
Zentalis Pharmaceuticals | ZNTL | Apr 29, 2024 | 11.42 | +3.26 |
Zentek | ZTEK | Apr 29, 2024 | 1.04 | -1.89 |
Zenvia A | ZENV | Apr 29, 2024 | 2.09 | -7.93 |
Zeo Energy A | ZEO | Apr 29, 2024 | 4.52 | 0.00 |
Zepp Health ADR | ZEPP | Apr 29, 2024 | 0.87 | +2.06 |
ZeroFox | ZFOX | Apr 29, 2024 | 1.14 | 0.00 |
Zeta Global A | ZETA | Apr 29, 2024 | 12.64 | -1.94 |
Zevia A | ZVIA | Apr 29, 2024 | 0.97 | +20.94 |
Zevra Therapeutics | ZVRA | Apr 29, 2024 | 4.55 | +0.66 |
Zhibao Technology | ZBAO | Apr 29, 2024 | 3.56 | 0.00 |
Zhihu A ADR | ZH | Apr 29, 2024 | 0.69 | +3.83 |
Zhongchao A | ZCMD | Apr 29, 2024 | 1.64 | -2.96 |
Ziff Davis | ZD | Apr 29, 2024 | 50.95 | -0.51 |
Zillow Group A | ZG | Apr 29, 2024 | 43.11 | -0.05 |
Zillow Group C Capital Stock | Z | Apr 29, 2024 | 43.65 | -0.05 |
ZIM | ZIM | Apr 29, 2024 | 13.07 | -1.13 |
Zimmer Biomet | ZBH | Apr 29, 2024 | 121.71 | +1.98 |
ZimVie | ZIMV | Apr 29, 2024 | 15.67 | -0.95 |
Zions Bank | ZION | Apr 29, 2024 | 41.32 | -1.05 |
Zions Bank A Pref | ZIONP | Apr 29, 2024 | 19.61 | +0.05 |
Zions Bank G Pref | ZIONO | Apr 29, 2024 | 25.52 | +0.08 |
ZipRecruiter A | ZIP | Apr 29, 2024 | 10.44 | +0.77 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.